Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Genitourinary Cancer|August 21, 2025
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical CystectomySalvador Jaime-Casas, Miguel Zugman, Regina Barragan-Carrillo, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
Clinical Genitourinary Cancer|July 26, 2023
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell CarcinomaNazli Dizman, Ameish Govindarajan, Zeynep B Zengin, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
Cancers|October 16, 2025
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder CancerSalvador Jaime-Casas, Wesley Yip, Daniel J Lama, et al.
JCO Oncology Practice|April 7, 2025
Assessment of Compliance With ASCO Language of Respect Guidelines in Renal Cell Carcinoma AbstractsNazli Dizman, Ruchi Agarwal, Daniela V Castro, et al.
JCO Global Oncology|March 7, 2020
Young Women With Breast Cancer in Mexico: Results of the Pilot Phase of the Joven & Fuerte Prospective CohortCynthia Villarreal-Garza, Alejandra Platas, Melina Miaja, et al.
European Urology Oncology|January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell CarcinomaZeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
Cancers|June 12, 2026
Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial AvailabilityKoral U Shah, Daniela V Castro, Xiaochen Li, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Pageof 4